Influence of the Valve Lubricant on the Aerodynamic Particle Size of a Metered Dose Inhaler

Drug Development and Industrial Pharmacy

Volumn 30, Issue 3, 2004, Pages 267-275

  Berry, Julianne ^a   Kline, Lukeysha ^a   Naini, Venkatesh ^a   Chaudhry, Saeed ^a   Hart, John ^a   Sequeira, Joel ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cascade impaction; Laser diffraction; Metered dose inhalers; Particle size; Valve lubricant

Indexed keywords

APAFLURANE; LUBRICATING AGENT; SILICONE OIL; STEROID;

ARTICLE; DRUG DELIVERY SYSTEM; FLOCCULATION; LASER DIFFRACTION; METERED DOSE INHALER; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PARTICLE SIZE; QUALITY CONTROL; SCANNING ELECTRON MICROSCOPY;

ADRENAL CORTEX HORMONES; AEROSOL PROPELLANTS; AEROSOLS; CHEMISTRY, PHYSICAL; HYDROCARBONS, FLUORINATED; LUBRICATION; METERED DOSE INHALERS; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; SILICONES; SURFACE-ACTIVE AGENTS; SUSPENSIONS; TECHNOLOGY, PHARMACEUTICAL;

EID: 1842507484     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120030420     Document Type: Article

References (28)

1. Dolovich, M. Characterization of medical aerosols: physical and clinical requirements for new inhalers. Aerosol Sci. Tech. 1995, 22, 392-399.
2. Elvecrog, J. Metered dose inhalers in a CFC-free future. Pharm. Technol. Eur. 1997, 9 (1), 52-55.
3. Keller, M. Innovations and perspectives of metered dose inhalers in pulmonary drug delivery. Int. J. Pharm. 1999, 186, 81-90.
4. Dolovich, M.B.; Ruffin, R.E.; Roberts, R.; Newhouse, M.T. Optimal delivery of aerosols from metered dose inhalers. Chest 1981, 80 (Suppl.), 911-915.
5. Meyer, K.C.; Auerbach, W.; Auerbach, R. Drug delivery to the lung. In Polymeric Site-Specific Pharmacotherapy; Domb, A.J., Ed.; John Wiley and Sons: New York, 1994; 347-367.
6. Pritchard, J.N. The influence of lung deposition on clinical responses. J. Aerosol Med. 2001, 14 (1), S19-S26.
7. Leach, C.L.; Davidson, P.J.; Boudreau, R.J. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur. Respir. J. 1998, 12, 1346-1353.
8. Matthys, H. Chlorofluorocarbon-free aerosol therapy in patients with pulmonary airflow obstruction. Respiration 1996, 63 (3), 321-324.
9. Milosovich, S. Particle size determination via cascade impaction. Pharm. Technol. 1992, 16, 82-86.
10. Johnsen, M.A. Properties of aerosol particles. Spray Technol. Mark. 1992, 2 (8), 46-55.
11. United States Pharmacopeia 25. 2001, 1969-1980. General Chapter 601.
12. Sequeira, J.; Berry, J.; Sharpe, S.; Naini, V.; Hart, J. A comparison of metered dose inhaler particle size distribution by andersen cascade impaction using two types of entry ports. Respir. Drug Deliv. VIII 2002, 2, 573-576.
13. Berry, J.; Heimbecher, S.; Hart, J.; Sequeira, J. Influence of the metering chamber volume and actuator design on the aerodynamic particle size of a metered dose inhaler. Drug Dev. Ind. Pharm. 2003, 29 (8), 865-876.
14. Ranucci, J. Dynamic plume-particle size analysis using laser diffraction. Pharm. Technol. 1992, 16, 108-114.
15. Witt, W.; Rothele, S. Laser diffraction-unlimited? Part. Syst. Character 1996, 13, 280-286.
16. Le Brun, P.P.H.; de Boer, A.H.; Gjaltema, D.; Hagedoorn, P.; Heijerman, H.G.M.; Frijlink, H.W. Inhalation of tobramycin in cystic fibrosis. Int. J. Pharm. 1999, 189 (2), 205-214.
17. Tzou, T.Z. Aerodynamic particle size of metered dose inhalers determined by the quartz crystal microbalance and the andersen cascade impactor. Int. J. Pharm. 1999, 186, 71-79.
18. Berry, J.; Kline, L.C.; Hart, J.; Sequeira, J. Influence of the storage position on the aerodynamic particle size of a suspension metered dose inhaler containing propellant HFA-227. Drug Dev. Ind. Pharm. 2003, 29 (6), 631-640.
19. Tzou, T.Z.; Pachuta, R.R.; Coy, R.B.; Schultz, R.K. Drug form selection in albuterol-containing metered-dose inhaler formulations and its impact on chemical and physical stability. J. Pharm. Sci. 1997, 86 (12), 1352-1357.
20. Parsons, G.E.; Buckton, G.; Chatham, S.M. The use of surface energy and polarity determinations to predict physical stability of non-polar, non-aqueous suspensions. Int. J. Pharm. 1992, 83, 163-170.
21. Ranucci, J.A.; Dixit, S.; Bray, R.N., Jr.; Goldman, D. Controlled flocculation in metered-dose aerosol suspensions. Pharm. Technol. 1990, 68-74.
22. Bower, C.; Washington, C.; Purewal, T.S. Characterization of surfactant effect on aggregates in model aerosol propellent suspensions. J. Pharm. Pharmacol. 1996, 48, 337-341.
23. Blackett, P.M.; Buckton, G. A microcalorimetric investigation of the interaction of surfactants with crystalline and partially crystalline salbutamol sulphate in a model inhalation aerosol system. Pharm. Res. 1995, 12 (11), 1689-1693.
24. Eriksson, P.M.; Sandstrom, K.B.; Rosenholm, J.B. The distribution of oleic acid between salbutamol base drug and different propellant blends. Pharm. Res. 1995, 12 (5), 715-719.
25. Hickey, A.J.; Dalby, R.N.; Byron, P.R. Effects of surfactants on aerosol powders in suspension. Implications for airborne particle size. Int. J. Pharm. 1988, 42 (1-3), 267-270.
26. Brambilla, G.; Ganderton, D.; Garzia, R.; Lewis, D.; Meakin, B.; Ventura, P. Modulation of aerosol clouds produced by pressurized inhalation aerosols. Int. J. Pharm. 1999, 186 (1), 53-61.
27. Dalby, R.N.; Byron, P.R. Comparison of output particle size distributions from pressurized aerosols formulated as solutions or suspensions. Pharm. Res. 1988, 5 (1), 36-39.
28. Evans, R.M.; Farr, S.J.; Armstrong, N.A.; Chatham, S.M. Formulation and in vitro evaluation of pressurized inhalation aerosols containing isotropic systems of lecithin and water. Pharm. Res. 1991, 8 (5), 629-635.